Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 20 (1), 22

Self-reported Medication in Community-Dwelling Older Adults in Germany: Results From the Berlin Initiative Study

Affiliations

Self-reported Medication in Community-Dwelling Older Adults in Germany: Results From the Berlin Initiative Study

Nina Mielke et al. BMC Geriatr.

Abstract

Background: Older adults have the highest drug utilization due to multimorbidity. Although the number of people over age 70 is expected to double within the next decades, population-based data on their medication patterns are scarce especially in combination with polypharmacy and potentially inappropriate medication (PIM). Our objective was to analyse the frequency of polypharmacy, pattern of prescription (PD) and over-the-counter (OTC) drug usage, and PIMs according to age and gender in a population-based cohort of very old adults in Germany.

Methods: Cross-sectional baseline data of the Berlin Initiative Study, a prospective cohort study of community-dwelling adults aged ≥70 years with a standardized interview including demographics, lifestyle variables, co-morbidities, and medication assessment were analysed. Medication data were coded using the Anatomical Therapeutic Chemical (ATC) classification. Age- and sex-standardized descriptive analysis of polypharmacy (≥5 drugs, PD and OTC vs. PD only and regular and on demand drugs vs regular only), medication frequency and distribution, including PIMs, was performed by age (</≥80) and gender.

Results: Of 2069 participants with an average age of 79.5 years, 97% (95%CI [96%;98%]) took at least one drug and on average 6.2 drugs (SD = 3.5) with about 40 to 66% fulfilling the criteria of polypharmacy depending on the definition. Regarding drug type more female participants took a combination of PD and OTC (male: 68%, 95%CI [65%;72%]); female: 78%, 95%CI [76%;80%]). Most frequently used were drugs for cardiovascular diseases (85%, 95%CI [83%;86%]). Medication frequency increased among participants aged ≥80 years, especially for cardiovascular drugs, antithrombotics, psychoanaleptics and dietary supplements. Among the top ten prescription drugs were mainly cardiovascular drugs including lipid-lowering agents (simvastatin), beta-blockers (metoprolol, bisoprolol) and ACE inhibitors (ramipril). The most common OTC drug was acetylsalicylic acid (35%; 95%CI [33%;37%])). Dose-independent PIM were identified for 15% of the participants.

Conclusions: Polypharmacy was excessive in older adults, with not only PD but also OTC drugs contributing to the high point prevalence. The medication patterns reflected the treatment of chronic diseases in this age group. There was even an increase in medication frequency between below and above 80 years especially for drugs of cardiovascular diseases, antithrombotic medication, psychoanaleptics, and dietary supplements.

Keywords: Epidemiology; Medication; Older adults; Over-the-counter drugs; Polypharmacy; Potentially inappropriate medication; Prescription drugs.

Conflict of interest statement

NM, AD, JG, MKK and PM declare that they have no competing interests. DH received travel reimbursement from Actelion, Switzerland, and Boehringer-Ingelheim, Germany. MvdG has received speaker honoraria from VIFOR-Pharma, Berlin Chemie, Bayer, Novartis and Otsuka and received travel grants from Otsuka. NE has received honoraria for lectures from Siemens Healthineers. ES has received honoraria for lectures from Siemens Healthineers, Fresenius Kabi and Fresenius Medical Care.

Figures

Fig. 1
Fig. 1
Medication categories by age (a) and gender (b). Data are presented on individual participant level; OTC (over-the-counter medication), PD (prescription medication)

Similar articles

See all similar articles

References

    1. Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350:h176. doi: 10.1136/bmj.h176. - DOI - PubMed
    1. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–995. doi: 10.1016/j.jclinepi.2012.02.018. - DOI - PubMed
    1. Elmståhl S, Linder H. Polypharmacy and Inappropriate Drug Use among Older People&mdash;a Systematic Review. Healthy Aging Clin Care Elderly. 2013;5(3642-HACCE-Polypharmacy-and-Inappropriate-Drug-Use-among-Older-People—a-Systema.pdf):1–8.
    1. Nobili A, Franchi C, Pasina L, Tettamanti M, Baviera M, Monesi L, et al. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiol Drug Saf. 2011;20(5):488–496. doi: 10.1002/pds.2108. - DOI - PubMed
    1. Franchi C, Tettamanti M, Pasina L, Djignefa CD, Fortino I, Bortolotti A, et al. Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-elderly project 2000-2010. Eur J Clin Pharmacol. 2014;70(4):437–443. doi: 10.1007/s00228-013-1621-6. - DOI - PubMed
Feedback